NCT Number: NCT01913106
Phase: Phase 1|Phase 2
Trial Summary: The purpose of this study is to conduct a Phase I – II clinical trial to extend preclinical studies involving in situ HSV-tk + Valacyclovir gene therapy in combination with brachyt – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): The Methodist Hospital Research Institute
Acronym:
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives